The forkhead transcription factor FOXL2 is expressed in somatic cells of the human ovary prior to follicle formation.
Interactions between germ cells and surrounding somatic cells are central to ovarian development as well as later function. Disruption of these interactions arising from abnormalities in either cell type can lead to premature ovarian failure (POF). The forkhead transcription factor FOXL2 is a candidate POF factor, and mutations in the FOXL2 gene are associated with syndromic and non-syndromic ovarian failure. Foxl2-deficient mice display major defects in primordial follicle activation with consequent follicle loss, and earlier roles in gonadal development and sex determination have also been suggested. However, despite its importance no data presently exist on its expression in the developing human ovary. Expression of FOXL2 mRNA was demonstrated in the human fetal ovary between 8 and 19 weeks gestation, thus from soon after sex determination to primordial follicle development. Expression in the ovary was higher after 14 weeks than at earlier gestation weeks and was very low in the fetal testis at all ages examined. Immunolocalization revealed FOXL2 expression to be confined to somatic cells, both adjacent to germ cells and those located in the developing ovarian stroma. These cells are the site of action of oocyte-derived activin signalling, but in vitro treatment of human fetal ovaries with activin failed to reveal any regulation of FOXL2 transcription by this pathway. In summary, the expression of FOXL2 in somatic cells of the developing human ovary before and during follicle formation supports a conserved and continuing role for this factor in somatic/germ cell interactions from the earliest stages of human ovarian development.
Duffin
K
K
Division of Reproductive and Developmental Sciences, Centre for Reproductive Biology, University of Edinburgh, Edinburgh, UK.
Bayne
R A L
RA
Childs
A J
AJ
Collins
C
C
Anderson
R A
RA
D028341:Activins / Q000378:metabolism; D000328:Adult; D000818:Animals; D005260:Female; D005333:Fetus / Q000033:anatomy & histology; D000074842:Forkhead Box Protein L2; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental; D006801:Humans; D008297:Male; D051379:Mice; D006080:Ovarian Follicle / Q000166:cytology / Q000502:physiology*; D010053:Ovary / Q000166:cytology / Q000196:embryology / Q000502:physiology; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
C421604:FOXL2 protein, human; D000074842:Forkhead Box Protein L2; D051858:Forkhead Transcription Factors; D012333:RNA, Messenger; D028341:Activins
Mol Hum Reprod. 2004 Jun;10(6):373-81
15044608
Genomics. 2002 Nov;80(5):465-72
12408963
BMC Dev Biol. 2007 Dec 18;7:136
18088417
Hum Mol Genet. 2004 Jun 1;13(11):1171-81
15056605
Dev Biol. 2004 Feb 15;266(2):334-45
14738881
Insect Biochem Mol Biol. 2007 Sep;37(9):985-97
17681238
Mol Cell Endocrinol. 2000 May 25;163(1-2):11-20
10963868
Nat Genet. 2001 Feb;27(2):159-66
11175783
J Clin Endocrinol Metab. 2009 Apr;94(4):1427-35
19258411
Int J Androl. 2002 Feb;25(1):59-64
11869379
J Pediatr Endocrinol Metab. 1995 Apr-Jun;8(2):127-33
7584707
Bioessays. 1991 Apr;13(4):151-6
1859392
Biol Reprod. 2002 Apr;66(4):1134-50
11906935
Dev Biol. 2008 Feb 1;314(1):189-99
18166170
Mol Cell Endocrinol. 2003 Aug 29;206(1-2):93-111
12943993
Nat Genet. 2001 Dec;29(4):453-8
11726932
Development. 2004 Feb;131(4):933-42
14736745
Dev Biol. 2006 Oct 1;298(1):132-48
16930587
BMC Dev Biol. 2009 Jun 18;9:36
19538736
Cytogenet Genome Res. 2003;101(3-4):206-11
14684984
Mamm Genome. 1996 Feb;7(2):133-7
8835530
J Clin Endocrinol Metab. 2005 Aug;90(8):4664-70
15914527
Hum Genet. 1988 Mar;78(3):260-6
3346015
Hum Mol Genet. 2005 Jul 15;14(14):2053-62
15944199
Hum Mol Genet. 2007 Dec 1;16(23):2795-804
17728319
Hum Reprod Update. 2005 Jul-Aug;11(4):391-410
15919682
Fertil Steril. 1988 Nov;50(5):747-51
3141218
J Anat. 1974 Jul;117(Pt 3):591-604
4608638
Am J Hum Genet. 2003 Feb;72(2):478-87
12529855
J Clin Endocrinol Metab. 2002 Jul;87(7):3417-27
12107261
Mol Hum Reprod. 2008 Dec;14(12):673-8
18996952
Cytogenet Genome Res. 2003;101(3-4):199-205
14684983
Hum Reprod. 2006 Jan;21(1):30-5
16155081
Dev Biol. 2002 Oct 1;250(1):1-23
12297093
Dev Growth Differ. 2006 Jun;48(5):297-308
16759280
Hum Mol Genet. 2001 Jul 15;10(15):1591-600
11468277
Mech Dev. 2009 May-Jun;126(5-6):324-36
19269320
Hum Reprod. 2004 Dec;19(12):2767-70
15459170
Nat Cell Biol. 2002 Oct;4 Suppl:s41-9
12479614
J Biol Chem. 2009 Mar 20;284(12):7631-45
19106105
Endocrinology. 2003 Jul;144(7):3237-43
12810580
Hum Reprod Update. 2006 Jan-Feb;12(1):65-76
16143663
Int J Dev Biol. 2000;44(6):575-80
11061420
Endocrinology. 2004 Jul;145(7):3424-33
15059956
Mol Cell Endocrinol. 2001 Jun 30;180(1-2):3-11
11451566
Physiol Rev. 1986 Jan;66(1):71-117
3511481
Am J Obstet Gynecol. 1986 Jul;155(1):189-95
3728585